Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by high throughput sequencing | TAB | Luca Massimino | |||||
GSE107370 |
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells
|
|
9 |
|
Luca Massimino | Nov 27, 2018 | ||
GSE109228 |
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice
|
|
6 |
|
Luca Massimino | Jan 16, 2019 | ||
GSE110990 |
Activation of the VEGFC/VEGFR3 pathway induces cancer immune escape through tumor-associated lymphatic vessels and macrophages in colorectal cancer
|
|
16 |
|
Luca Massimino | Mar 17, 2020 | ||
GSE133090 |
Transcriptional profiling of Setd5 mutant cortical tissue
|
|
6 |
|
Luca Massimino | Sep 16, 2019 | ||
GSE133554 |
CRISPRa-mediated Kcna1 upregulation decreases neuronal excitability and suppresses seizures in a rodent model of temporal lobe epilepsy [I]
|
|
17 |
|
Luca Massimino | Nov 15, 2019 | ||
GSE133755 |
In vitro restoration of Friedreich's Ataxia defect with novel Cas9-edited hiPSC-derived Dorsal Root Ganglion-like Organoids (DRGOs) and Microfluidic System
|
|
3 |
|
Luca Massimino | Jul 27, 2020 | ||
GSE133930 |
CRISPRa-mediated Kcna1 upregulation decreases neuronal excitability and suppresses seizures in a rodent model of temporal lobe epilepsy
|
|
23 |
|
Luca Massimino | Nov 15, 2019 | ||
GSE157020 |
TSG-6 supports fistulizing Crohn’s disease by a mechanoregulated activation of the epithelial-to-mesenchymal transition
|
|
30 |
|
Luca Massimino | Jan 04, 2023 | ||
GSE157533 |
Microglia-specific overexpression of alpha-Synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity [bulk RNA-Seq]
|
|
9 |
|
Luca Massimino | Sep 13, 2021 | ||
GSE157536 |
Microglia-specific overexpression of alpha-Synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity
|
|
11 |
|
Luca Massimino | Sep 13, 2021 | ||
GSE212252 |
Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition
|
|
80 |
|
Luca Massimino | Sep 12, 2022 |